Dendritic Cell Cancer Vaccine Global Market Report 2025

Dendritic Cell Cancer Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dendritic cell cancer vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for dendritic cell cancer vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dendritic cell cancer vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Product: CreaVax; Sipuleucel-T (Provenge); Other Products

2) By Distribution Channel: Hospitals; Cancer Centers; Ambulatory Surgical Centers; Clinics

3) By Application: Pediatrics; Adults

4) By End User: Oncology; Research Institutions; Biopharmaceutical Companies

Subsegments:

1) By Creavax: Creavax In Clinical Trials; Creavax Commercialization

2) By Sipuleucel-T (Provenge): Sipuleucel-T In Prostate Cancer; Sipuleucel-T Market Share; Sipuleucel-T Regulatory Approvals

3) By Other Products: Dcvax; Oncovax; GVAX; Other Experimental Dendritic Cell Vaccines

Companies Mentioned: Dendreon Pharmaceuticals LLC; Celgene Corporation; Cognate BioServices Inc.; APAC Biotech; Asterias Biotherapeutics Inc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Dendritic Cell Cancer Vaccine market Characteristics
3. Dendritic Cell Cancer Vaccine market Trends And Strategies
4. Dendritic Cell Cancer Vaccine market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Dendritic Cell Cancer Vaccine Growth Analysis And Strategic Analysis Framework
5.1. Global Dendritic Cell Cancer Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Dendritic Cell Cancer Vaccine market Growth Rate Analysis
5.4. Global Dendritic Cell Cancer Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Dendritic Cell Cancer Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Dendritic Cell Cancer Vaccine Total Addressable Market (TAM)
6. Dendritic Cell Cancer Vaccine market Segmentation
6.1. Global Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CreaVax
Sipuleucel-T (Provenge)
Other Products
6.2. Global Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Cancer Centers
Ambulatory Surgical Centers
Clinics
6.3. Global Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatrics
Adults
6.4. Global Dendritic Cell Cancer Vaccine market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Research Institutions
Biopharmaceutical Companies
6.5. Global Dendritic Cell Cancer Vaccine Market, Sub-Segmentation Of Creavax, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Creavax In Clinical Trials
Creavax Commercialization
6.6. Global Dendritic Cell Cancer Vaccine Market, Sub-Segmentation Of Sipuleucel-T (Provenge), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sipuleucel-T In Prostate Cancer
Sipuleucel-T Market Share
Sipuleucel-T Regulatory Approvals
6.7. Global Dendritic Cell Cancer Vaccine Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dcvax
Oncovax
GVAX
Other Experimental Dendritic Cell Vaccines
7. Dendritic Cell Cancer Vaccine market Regional And Country Analysis
7.1. Global Dendritic Cell Cancer Vaccine market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Dendritic Cell Cancer Vaccine market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Dendritic Cell Cancer Vaccine market
8.1. Asia-Pacific Dendritic Cell Cancer Vaccine market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Dendritic Cell Cancer Vaccine market
9.1. China Dendritic Cell Cancer Vaccine market Overview
9.2. China Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Dendritic Cell Cancer Vaccine market
10.1. India Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Dendritic Cell Cancer Vaccine market
11.1. Japan Dendritic Cell Cancer Vaccine market Overview
11.2. Japan Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Dendritic Cell Cancer Vaccine market
12.1. Australia Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Dendritic Cell Cancer Vaccine market
13.1. Indonesia Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Dendritic Cell Cancer Vaccine market
14.1. South Korea Dendritic Cell Cancer Vaccine market Overview
14.2. South Korea Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Dendritic Cell Cancer Vaccine market
15.1. Western Europe Dendritic Cell Cancer Vaccine market Overview
15.2. Western Europe Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Dendritic Cell Cancer Vaccine market
16.1. UK Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Dendritic Cell Cancer Vaccine market
17.1. Germany Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Dendritic Cell Cancer Vaccine market
18.1. France Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Dendritic Cell Cancer Vaccine market
19.1. Italy Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Dendritic Cell Cancer Vaccine market
20.1. Spain Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Dendritic Cell Cancer Vaccine market
21.1. Eastern Europe Dendritic Cell Cancer Vaccine market Overview
21.2. Eastern Europe Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Dendritic Cell Cancer Vaccine market
22.1. Russia Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Dendritic Cell Cancer Vaccine market
23.1. North America Dendritic Cell Cancer Vaccine market Overview
23.2. North America Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Dendritic Cell Cancer Vaccine market
24.1. USA Dendritic Cell Cancer Vaccine market Overview
24.2. USA Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Dendritic Cell Cancer Vaccine market
25.1. Canada Dendritic Cell Cancer Vaccine market Overview
25.2. Canada Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Dendritic Cell Cancer Vaccine market
26.1. South America Dendritic Cell Cancer Vaccine market Overview
26.2. South America Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Dendritic Cell Cancer Vaccine market
27.1. Brazil Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Dendritic Cell Cancer Vaccine market
28.1. Middle East Dendritic Cell Cancer Vaccine market Overview
28.2. Middle East Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Dendritic Cell Cancer Vaccine market
29.1. Africa Dendritic Cell Cancer Vaccine market Overview
29.2. Africa Dendritic Cell Cancer Vaccine market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Dendritic Cell Cancer Vaccine market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Dendritic Cell Cancer Vaccine market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Dendritic Cell Cancer Vaccine market Competitive Landscape And Company Profiles
30.1. Dendritic Cell Cancer Vaccine market Competitive Landscape
30.2. Dendritic Cell Cancer Vaccine market Company Profiles
30.2.1. Dendreon Pharmaceuticals LLC Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Celgene Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Cognate BioServices Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. APAC Biotech Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Asterias Biotherapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Dendritic Cell Cancer Vaccine market Other Major And Innovative Companies
31.1. Batavia Biosciences
31.2. Medigene AG
31.3. Zelluna Immunotherapy AS
31.4. Diakonos Oncology
31.5. Elios Therapeutics LLC
31.6. Northwest Biotherapeutics
31.7. Oncopep Inc.
31.8. PDC*line Pharma SA
31.9. SillaJen Biotherapeutics Inc.
31.10. VLP Therapeutics
31.11. ImmunityBio Inc.
31.12. Celldex Therapeutics Inc.
31.13. Bellicum Pharmaceuticals
31.14. Argos Therapeutics Inc.
31.15. DCPrime
32. Global Dendritic Cell Cancer Vaccine market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Dendritic Cell Cancer Vaccine market
34. Recent Developments In The Dendritic Cell Cancer Vaccine market
35. Dendritic Cell Cancer Vaccine market High Potential Countries, Segments and Strategies
35.1 Dendritic Cell Cancer Vaccine market In 2029 - Countries Offering Most New Opportunities
35.2 Dendritic Cell Cancer Vaccine market In 2029 - Segments Offering Most New Opportunities
35.3 Dendritic Cell Cancer Vaccine market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings